4//SEC Filing
Reine Allan 4
Accession 0001562180-21-005284
CIK 0001822462other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:14 PM ET
Size
7.1 KB
Accession
0001562180-21-005284
Insider Transaction Report
Form 4
Reine Allan
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Options (Right to buy)
2021-08-09+26,892→ 257,512 totalExercise: $3.72Exp: 2029-09-16→ Common Stock (26,892 underlying) - Exercise/Conversion
Common Stock
2021-08-09$3.72/sh+26,892$100,038→ 53,784 total
Footnotes (1)
- [F1]The option vested as to 25% of the underlying shares of common stock on September 16, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0001714023
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 4:14 PM ET
- Size
- 7.1 KB